Company Description
CeriBell, Inc. operates as a medical technology company in the United States.
It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.
In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data.
The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
| Country | United States |
| Founded | 2014 |
| IPO Date | Oct 11, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 327 |
| CEO | Xingjuan Chao |
Contact Details
Address: 360 North Pastoria Avenue Sunnyvale, California 94085 United States | |
| Phone | 800 436 0826 |
| Website | ceribell.com |
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001861107 |
| CUSIP Number | 15678C102 |
| ISIN Number | US15678C1027 |
| Employer ID | 47-1785452 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xingjuan Chao Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
| Dr. Josef Parvizi M.D., Ph.D. | Co-Founder, Chief Medical Advisor and Director |
| Scott Blumberg | Chief Financial Officer |
| Dr. Raymond Woo Ph.D. | Chief Technology Officer |
| Dan Rogy | Senior Vice President of Operations |
| Louisa Daniels J.D., M.B.A. | General Counsel |
| Brian P. Price | Senior Vice President of Marketing |
| Kim McKeon | Vice President of People and Culture |
| Baharan Kamousi Ph.D. | Senior Vice President of Data Science |
| Joseph Sean Manni | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 20, 2026 | ARS | Filing |
| Apr 20, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 20, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 6, 2026 | 144 | Filing |
| Apr 1, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Mar 2, 2026 | 144 | Filing |
| Feb 24, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |